Towards Healthcare

NEWS & INSIGHTS

Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.

Dalton Pharma Proceeds with Other Activities to Manufacture Nanoparticle Formulations
Date 24 September 2025

Dalton Pharma Proceeds with Other Activities to Manufacture Nanoparticle Formulations

Image Credits: PitchBook Announcement The onco-innovations limited is proud to confirm that Dalton Pharma Services has proceeded with activities for manufacturing onco’s exclusive nanopart...

Leo Pharma's New Scientific Data to Cure Chronic Hand Eczema (CHE)
Date 23 September 2025

Leo Pharma's New Scientific Data to Cure Chronic Hand Eczema (CHE)

Image Credits: PharmaPhorum Announcement The LEO Pharma A/S a a leading medical dermatology company, revealed two late-breaking delgocitinib cream data for chronic hand eczema (CHE), featuring the...

Innovent's Partner Ollin Reports on the Clinical Study of IBI324
Date 22 September 2025

Innovent's Partner Ollin Reports on the Clinical Study of IBI324

Image Credits: Innovent Biologics Announcement Innovent Biologics Inc., a leading biopharmaceutical company that establishes commercialization and manufacturing of high-quality medicines for the t...

Neurocrine's New Data to be Revealed at the 38th Annual Psych Congress 2025
Date 19 September 2025

Neurocrine's New Data to be Revealed at the 38th Annual Psych Congress 2025

Image Credits: Neurocrine Biosciences Announcement Neurocrine Biosciences Inc. confirms that it will showcase the new data from the phase 2 SAVITRI study of osavampator in adults with crucial depr...

Viridian's Enrollment Completion of REVEAL Clinical Trials
Date 18 September 2025

Viridian's Enrollment Completion of REVEAL Clinical Trials

Image Credits: Ophthalmology Times Announcement Viridian Therapeutics Inc., a leading biotechnology company committed to developing, commercializing, and exploring capable medicines for rare and s...

Galimedix Therapeutics, Completion of Phase 1 Study with GAL-101
Date 17 September 2025

Galimedix Therapeutics, Completion of Phase 1 Study with GAL-101

Image credits: Optometry Times Announcement Galimedix Therapeutics Inc., a leading phase 2 clinical stage biotechnology company establishing topical neuroprotective and novel therapies with the ca...

Six Biotech Startups Redefining Aging and Skin Health with Cutting-Edge Innovations
Date 10 July 2025

Six Biotech Startups Redefining Aging and Skin Health with Cutting-Edge Innovations

Six Biotech Companies’Initiative to Shape the Evergreen Age Announcement The modern era, which is experiencing and adopting computational techniques and deep biological knowledge, expects a ch...

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.